3/2
12:49 pm
pfe
Rating for PFE
Low
Report
Rating for PFE
3/2
08:03 am
pfe
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
Low
Report
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
3/2
08:03 am
pfe
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
Low
Report
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
3/2
07:29 am
pfe
Pfizer upgraded to Buy from Hold at Argus
Low
Report
Pfizer upgraded to Buy from Hold at Argus
3/2
07:29 am
pfe
Pfizer upgraded to Buy from Hold at Argus
Low
Report
Pfizer upgraded to Buy from Hold at Argus
2/26
06:28 am
pfe
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
Low
Report
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
2/26
06:28 am
pfe
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
Low
Report
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
2/25
09:59 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/25
09:59 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/24
04:06 pm
pfe
Pfizer initiated with an Underperform at RBC Capital
Low
Report
Pfizer initiated with an Underperform at RBC Capital
2/24
04:06 pm
pfe
Pfizer initiated with an Underperform at RBC Capital
Low
Report
Pfizer initiated with an Underperform at RBC Capital
2/21
06:31 am
pfe
Pfizer (NYSE:PFE) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
Low
Report
Pfizer (NYSE:PFE) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
2/20
10:01 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/20
10:01 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/19
08:01 pm
pfe
Pfizer (NYSE:PFE) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.
Low
Report
Pfizer (NYSE:PFE) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.
2/19
04:17 pm
pfe
Pfizer initiated with an Underweight at Barclays
Low
Report
Pfizer initiated with an Underweight at Barclays
2/19
04:17 pm
pfe
Pfizer initiated with an Underweight at Barclays
Low
Report
Pfizer initiated with an Underweight at Barclays
2/12
05:10 am
pfe
Pfizer downgraded to Neutral from Outperform at Daiwa
Low
Report
Pfizer downgraded to Neutral from Outperform at Daiwa
2/4
11:36 am
pfe
Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $27.00 price target on the stock.
Low
Report
Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $27.00 price target on the stock.
2/4
11:18 am
pfe
Rating for PFE
Low
Report
Rating for PFE
1/27
01:02 pm
pfe
Rating for PFE
Low
Report
Rating for PFE
1/27
08:04 am
pfe
Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Pfizer (NYSE:PFE) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
1/7
08:44 am
pfe
Rating for PFE
Low
Report
Rating for PFE
12/17
10:28 am
pfe
Rating for PFE
Low
Report
Rating for PFE
12/17
10:28 am
pfe
Rating for PFE
Low
Report
Rating for PFE